ArticleCureus2026
Primary Dedifferentiated Liposarcoma of the Duodenum: A Report of a Rare Case With a Review of the Literature.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary and metastatic tumors of the duodenum are rare, and primary duodenal dedifferentiated liposarcomas (DDLPS) of this region are exceptionally uncommon. DDLPS is an aggressive malignancy characterized by a high risk of recurrence and metastasis. This report describes the case of a 43-year-old woman who presented with a 20-day history of isolated abdominal pain. CT images demonstrated a 68 x 120 mm lesion involving the distal portions of the duodenum. Intraoperatively, the lesion was found to be confined to the third and fourth portions, and a segmental duodenal resection with duodenojejunostomy using a circular stapler was performed. During the postoperative period, the patient experienced transient cholestatic findings likely secondary to papillary obstruction. After clinical improvement, she was lost to follow-up for seven months during doxorubicin therapy and later re-presented with extensive metastatic disease, ultimately resulting in death. Given the extremely limited number of similar cases, no standardized treatment strategy exists. This case highlights the importance of considering DDLPS in the differential diagnosis of duodenal masses, even in patients presenting with nonspecific symptoms, and provides additional insight that may guide clinical decision-making in future cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.